WARUNEE NOWAK: Open Payments
NPI 1215636444 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 59 payments from 20 companies in 2025. Trend: 2023 $169 · 2024 $376 · 2025 $1,574
Food & beverage: $1,375Education: $199
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $308 |
| Novartis Pharmaceuticals Corporation | 9 | $255 |
| Amgen Inc. | 4 | $201 |
| ABBVIE INC. | 8 | $157 |
| Incyte Corporation | 6 | $125 |
| GENZYME CORPORATION | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| PFIZER INC. | 2 | $39 |
| Janssen Biotech, Inc. | 2 | $39 |
Products named: OTEZLA, DUPIXENT, OPZELURA, Rhapsido, ILUMYA, SKYRIZI, RINVOQ, Sotyktu.
Industry payments across FL — which companies pay providers there.
